Skip to main content
OpenTrials

Clinical trial condition

Venous Thrombosis

Explore clinical trials studying Venous Thrombosis. Study availability and eligibility vary by location and protocol.

229 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Venous Thrombosis trial results

Completed

Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)

NCT01976338

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +15 more
Locations
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Beijing, Beijing Municipality, China
  • Novartis Investigative Site Chongqing, Chongqing Municipality, China
  • Novartis Investigative Site Guangzhou, Guangdong, China
View all 33 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion

NCT01377597

Conditions
Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +14 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Fukuoka, Japan
  • Novartis Investigative Site Kita-gun, Kagawa-ken, Japan
View Trial Details
Completed

Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion

NCT01599650

Conditions
Branch Retinal Vein Occlusion, Cardiovascular Diseases, Embolism and Thrombosis, +15 more
Locations
  • Novartis Investigative Site Parramatta, New South Wales, Australia
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 82 locations
View Trial Details
Completed

Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion

NCT01535261

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +9 more
Locations
  • Novartis Investigative Site Parramatta, New South Wales, Australia
  • Novartis Investigative Site Sydney, New South Wales, Australia
  • Novartis Investigative Site Melbourne, Victoria, Australia
  • Novartis Investigative Site Nedlands, Western Australia, Australia
View all 78 locations
View Trial Details
Completed

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO)

NCT01396083

Conditions
Cardiovascular Diseases, Central Retinal Vein Occlusion, Embolism and Thrombosis, +16 more
Locations
  • Novartis Investigative Site Leipzig, Germany
  • Novartis Investigative Site Regensburg, Germany
  • Novartis Investigative Site Augsburg, Germany
  • Novartis Investigative Site Bad Rothenfelde, Germany
View all 64 locations
View Trial Details

Related conditions